Recommended
Recommended
Recent Quotes
My Watchlist
Indicators
Local Stocks
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aveo Pharmaceuticals (NQ: AVEO )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Jan 19, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 14.99 (49)
Ask (Size) 15.00 (111)
Prev. Close 15.00
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 34,373,995
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire

Performance

More News

Read More
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Aveo Stock Continues Its Bullish Run After Snagging $566 Million LG Chem Buyout
Via Investor's Business Daily
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
LG Chem Completes Acquisition of AVEO Oncology
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
AVEO Oncology Stockholders Approve Acquisition by LG Chem
From AVEO Pharmaceuticals, Inc.
Via GlobeNewswire
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Altra Industrial Motion Corp. (Nasdaq - AIMC), UserTesting, Inc. (NYSE - USER), AVEO Pharmaceuticals, Inc. (Nasdaq - AVEO), Limestone Bancorp, Inc. (Nasdaq - LMST)
From Brodsky & Smith LLC
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2022
Via Benzinga
US Stock Futures Lower Following Friday's Rally; Tesla In Focus
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2022
Via Benzinga
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
Via Benzinga
Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday
Via Benzinga
AVEO ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AVEO Oncology - AVEO
From Kahn Swick & Foti, LLC
Via Business Wire
Crude Oil Drops Over 2%; Akouos Shares Spike Higher
Via Benzinga
Nasdaq Rises Over 100 Points; Goldman Sachs Tops Q3 Views
Via Benzinga
Why Akouos Shares Are Trading Sharply Higher? Here Are 36 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Zovio (ZVO) Stock Soars 90% Ahead of Oct. 25 Dissolution Vote
Via InvestorPlace
Looking Into AVEO Pharmaceuticals's Recent Short Interest
Via Benzinga
Why Is Ra Medical (RMED) Stock Up 25% Today?
Via InvestorPlace
US Stocks Extend Monday's Gains; Dow Jumps Over 500 Points
Via Benzinga
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
Via InvestorPlace
Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.